Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › IL › Des Plaines › NPI 1316306152
NP / PA

Niewiarowski, Ketina

Niewiarowski, Ketina was paid $221K by Medicaid between Feb 2018 and Dec 2024, across 9 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 48% of everything it billed.

33Billing provider infoNIEWIAROWSKI, KETINA
DES PLAINES, IL 60016
33aNPI1316306152assigned 02/22/2016
28Total paid$221K
24GClaims3,985
24DCodes billed9
24AFirst – last monthFeb 2018 – Dec 2024
Compared with peers

Next to other Family Nurse Practitioner providers in Illinois

Rank by total paid#310 of 3,353
Median peer was paid$25K
This provider vs. median9.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$5.0K$10K$15K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201861$3K
2019177$10K
2020242$15K
2021730$29K
20221,131$62K
2023991$61K
2024incomplete653$40K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 48% 2,241 2,067 $107K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 24% 372 358 $52K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 12% 441 349 $27K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 8.5% 427 401 $19K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 3.2% 204 182 $7K
99203 Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity 1.3% 63 57 $3K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1.3% 56 47 $3K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 1.0% 148 137 $2K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 33 31 $1K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.